了解前列腺癌多基因风险评分的生物学基础及差异:一项全面的基因组分析

Understanding the Biological Basis of Polygenic Risk Scores and Disparities in Prostate Cancer: A Comprehensive Genomic Analysis.

作者信息

Zhang Wensheng, Zhang Kun

机构信息

Bioinformatics Core of Xavier NIH RCMI Center of Cancer Research, Xavier University of Louisiana, New Orleans, LA, USA.

Department of Computer Science, Xavier University of Louisiana, New Orleans, LA, USA.

出版信息

Cancer Inform. 2024 Oct 21;23:11769351241276319. doi: 10.1177/11769351241276319. eCollection 2024.

Abstract

OBJECTIVES

For prostate cancer (PCa), hundreds of risk variants have been identified. It remains unknown whether the polygenic risk score (PRS) that combines the effects of these variants is also a sufficiently informative metric with relevance to the molecular mechanisms of carcinogenesis in prostate. We aimed to understand the biological basis of PRS and racial disparities in the cancer.

METHODS

We performed a comprehensive analysis of the data generated (deposited in) by several genomic and/or transcriptomic projects (databases), including the GTEx, TCGA, 1000 Genomes, GEO and dbGap. PRS was constructed from 260 PCa risk variants that were identified by a recent trans-ancestry meta-analysis and contained in the GTEx dataset. The dosages of risk variants and the multi-ancestry effects on PCa incidence estimated by the meta-analysis were used in calculating individual PRS values.

RESULTS

The following novel results were obtained from our analyses. (1) In normal prostate samples from healthy European Americans (EAs), the expression levels of 540 genes (termed PRS genes) were associated with the PRS ( < .01). (2) Ubiquitin-proteasome system in high-PRS individuals' prostates was more active than that in low-PRS individuals' prostates. (3) Nine PRS genes play roles in the cancer progression-relevant parts, which are frequently hit by somatic mutations in PCa, of PI3K-Akt/RAS-MAPK/mTOR signaling pathways. (4) The expression profiles of the top significant PRS genes in tumor samples were capable of predicting malignant PCa relapse after prostatectomy. (5) The transcriptomic differences between African American and EA samples were incompatible with the patterns of the aforementioned associations between PRS and gene expression levels.

CONCLUSIONS

This study provided unique insights into the relationship between PRS and the molecular mechanisms of carcinogenesis in prostate. The new findings, alongside the moderate but significant heritability of PCa susceptibility contributed by the risk variants, suggest the aptness and inaptness of PRS for explaining PCa and disparities.

摘要

目的

对于前列腺癌(PCa),已鉴定出数百个风险变异。将这些变异的效应结合起来的多基因风险评分(PRS)是否也是一个与前列腺癌发生的分子机制相关且信息充分的指标,目前尚不清楚。我们旨在了解PRS的生物学基础以及该癌症中的种族差异。

方法

我们对几个基因组和/或转录组项目(数据库)产生(存储)的数据进行了全面分析,包括GTEx、TCGA、千人基因组计划、GEO和dbGap。PRS由最近一项跨种族荟萃分析鉴定并包含在GTEx数据集中的260个PCa风险变异构建而成。荟萃分析估计的风险变异剂量和对PCa发病率的多血统效应用于计算个体PRS值。

结果

我们的分析得出了以下新结果。(1)在健康欧裔美国人(EA)的正常前列腺样本中,540个基因(称为PRS基因)的表达水平与PRS相关(<0.01)。(2)高PRS个体前列腺中的泛素-蛋白酶体系统比低PRS个体前列腺中的更活跃。(3)9个PRS基因在PI3K-Akt/RAS-MAPK/mTOR信号通路与癌症进展相关的部分发挥作用,这些部分在PCa中经常受到体细胞突变的影响。(4)肿瘤样本中最显著的PRS基因的表达谱能够预测前列腺切除术后恶性PCa的复发。(5)非裔美国人和EA样本之间的转录组差异与上述PRS和基因表达水平之间的关联模式不相符。

结论

本研究为PRS与前列腺癌发生的分子机制之间的关系提供了独特见解。这些新发现,连同风险变异对PCa易感性的中等但显著的遗传度,表明了PRS用于解释PCa及其差异的适用性和不适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c6/11497523/ceee73a03221/10.1177_11769351241276319-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索